Vanguard Group Inc Revolution Medicines, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RVMD
# of Institutions
341Shares Held
195MCall Options Held
908KPut Options Held
723K-
Farallon Capital Management LLC San Francisco, CA14.3MShares$850 Million2.37% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$796 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$628 Million0.2% of portfolio
-
Wellington Management Group LLP Boston, MA10.3MShares$609 Million0.07% of portfolio
-
Baker Bros. Advisors LP New York, NY9.36MShares$556 Million3.49% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $5.2B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...